Search - tctmd.com

Displaying 281 - 300 of 498

Sort: Relevancy | Date

Triple Antiplatelet Therapy Does Not Reduce Recurrent Events in Patients With Acute Ischemic Stroke or TIA

News Conference News ISC 2017

Triple Antiplatelet Therapy Does Not Cut New Events in Acute Ischemic Stroke or TIA

Todd Neale

February 23, 2017

Presentation ISET 2017

Imaging of Acute Stroke: What You Need to Make a Decision to Treat

Presenter: Kevin Abrams

February 04, 2017

News Daily News

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Michael O'Riordan

January 17, 2017

News Daily News

FDA’s Latest Move Against Aspirin for CVD Primary Prevention: A Picture Is Worth 11 Words

Shelley Wood

January 13, 2017

News Daily News

Perioperative MACCE Rate Falls but Ischemic Stroke Rises Among Noncardiac Surgery Patients

Yael L. Maxwell

January 04, 2017

PFO and Migraine? New Study Zeros in on Atrial Septal Aneurysms

News Daily News

¿FOP y Migrañas? Un Nuevo Estudio se Centra en los Aneurismas del Tabique Interauricular

Shelley Wood

December 08, 2016

News Conference News AHA 2016

Errar la Dosis de NOAC en la Práctica Clínica Diaria es algo Habitual, lo cual tiene Implicaciones en Materia de ACV y Hemorragias

Shelley Wood

November 21, 2016

News Daily News

Carotid Stenting Outcomes Not Linked to Hospital Case Volume in German Registry

L.A. McKeown

November 18, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

News Daily News

La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes

Yael L. Maxwell

October 28, 2016

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Daily News

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Michael O'Riordan

October 11, 2016

News Daily News

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Michael O'Riordan

October 07, 2016

News Daily News

Rapid Treatment Remains Key for Thrombectomy in Acute Stroke but Still Works Several Hours After Onset

Todd Neale

September 27, 2016

News Daily News

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

News Daily News

Los Grandes Cambios en la Presión Arterial Sistólica de una Visita Médica a Otra se asocian a un Mayor Riesgo de Mortalidad

Michael O'Riordan

September 27, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Daily News

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Shelley Wood

September 13, 2016

News Daily News

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

Yael L. Maxwell

September 02, 2016

Advertisement

Triple Antiplatelet Therapy Does Not Cut New Events in Acute Ischemic Stroke or TIA

Imaging of Acute Stroke: What You Need to Make a Decision to Treat

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

FDA’s Latest Move Against Aspirin for CVD Primary Prevention: A Picture Is Worth 11 Words

Perioperative MACCE Rate Falls but Ischemic Stroke Rises Among Noncardiac Surgery Patients

¿FOP y Migrañas? Un Nuevo Estudio se Centra en los Aneurismas del Tabique Interauricular

Errar la Dosis de NOAC en la Práctica Clínica Diaria es algo Habitual, lo cual tiene Implicaciones en Materia de ACV y Hemorragias

Carotid Stenting Outcomes Not Linked to Hospital Case Volume in German Registry

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Rapid Treatment Remains Key for Thrombectomy in Acute Stroke but Still Works Several Hours After Onset

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Los Grandes Cambios en la Presión Arterial Sistólica de una Visita Médica a Otra se asocian a un Mayor Riesgo de Mortalidad

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content